National Pension Service Grows Stock Position in Axon Enterprise, Inc $AXON

National Pension Service raised its position in Axon Enterprise, Inc (NASDAQ:AXON) by 18.4% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 118,234 shares of the biotechnology company’s stock after acquiring an additional 18,398 shares during the period. National Pension Service’s holdings in Axon Enterprise were worth $66,283,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise in the 4th quarter worth about $28,000. Keating Financial Advisory Services Inc. bought a new stake in Axon Enterprise in the 2nd quarter valued at about $31,000. AlphaCentric Advisors LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at about $34,000. Darwin Wealth Management LLC purchased a new stake in Axon Enterprise during the second quarter valued at about $37,000. Finally, Washington Trust Advisors Inc. boosted its position in Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after purchasing an additional 65 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Argus boosted their price target on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. The Goldman Sachs Group reiterated a “buy” rating and issued a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. Morgan Stanley boosted their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, UBS Group increased their target price on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research report on Thursday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $721.57.

Axon Enterprise Stock Up 0.1%

AXON stock opened at $479.34 on Friday. The stock has a 50-day simple moving average of $561.67 and a two-hundred day simple moving average of $488.36. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $792.16. The firm has a market capitalization of $38.94 billion, a PE ratio of 198.90, a PEG ratio of 9.01 and a beta of 1.40. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same period in the prior year, the firm posted $2.12 earnings per share. The company’s revenue for the quarter was up 35.3% on a year-over-year basis. On average, equities analysts predict that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.

Insider Buying and Selling

In other news, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at $61,266,818.70. This trade represents a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 66,380 shares of company stock valued at $37,672,266. Company insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and equipment for law enforcement, public safety and other government agencies. Its product portfolio includes TASER energy weapons, body-worn cameras, in-car cameras and related connected devices designed to support safer interactions, improve transparency and collect operational data.

The company also provides cloud-based software for managing digital evidence, conducting investigations, overseeing records and workflows, coordinating dispatch and supporting real-time public safety operations.